Diaxonhit SA Stock Euronext Paris
Equities
ALEHT
FR0004054427
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
May. 08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
May. 08 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
Sales 2024 * | 138M 148M | Sales 2025 * | 148M 159M | Capitalization | 151M 162M |
---|---|---|---|---|---|
Net income 2024 * | 9M 9.67M | Net income 2025 * | 11M 11.81M | EV / Sales 2024 * | 1.02 x |
Net cash position 2024 * | 9.9M 10.63M | Net cash position 2025 * | 32.8M 35.23M | EV / Sales 2025 * | 0.8 x |
P/E ratio 2024 * |
15.8
x | P/E ratio 2025 * |
12.4
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 61.33% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director of Finance/CFO | 43 | 22-09-30 | |
Cathie Marsais
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director/Board Member | 68 | 09-11-03 | |
Director/Board Member | 67 | 17-06-14 |
1st Jan change | Capi. | |
---|---|---|
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock